Theravance Biopharma Presents Positive Phase 2 Study Data on Velusetragfor Treatment of Gastroparesis
May 18, 2015 at 08:06 AM EDT
Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma" or the "Company") today announced the presentation of positive data ...